Serum Apolipoprotein C-III and Cardiovascular Events in Type 1 Diabetes

被引：0
|
作者：
Basu, Arpita
Bebu, Ionut
Jenkins, Alicia
Stoner, Julie
Zhang, Ying
Klein, Richard L.
Lopes-Virella, Maria F.
Garvey, W. Timothy
Budoff, Matthew
Lyons, Timothy
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-188-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
    Gaudet, Daniel
    Alexander, Veronica J.
    Baker, Brenda F.
    Brisson, Diane
    Tremblay, Karine
    Singleton, Walter
    Geary, Richard S.
    Hughes, Steven G.
    Viney, Nicholas J.
    Graham, Mark J.
    Crooke, Rosanne M.
    Witztum, Joseph L.
    Brunzell, John D.
    Kastelein, John J. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (05): : 438 - 447
  • [42] Apolipoprotein C-III in patients with systemic lupus erythematosus
    Martin-Gonzalez, Candelaria
    Ferrer-Moure, Carmen
    Carlos Quevedo-Abeledo, Juan
    de Vera-Gonzalez, Antonia
    Gonzalez-Delgado, Alejandra
    Sanchez-Martin, Julio
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [43] Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia
    Adiels, Martin
    Taskinen, Marja-Riitta
    Bjornson, Elias
    Andersson, Linda
    Matikainen, Niina
    Soderlund, Sanni
    Kahri, Juhani
    Hakkarainen, Antti
    Lundbom, Nina
    Sihlbom, Carina
    Thorsell, Annika
    Zhou, Haihong
    Pietilainen, Kirsi H.
    Packard, Chris
    Boren, Jan
    DIABETES OBESITY & METABOLISM, 2019, 21 (08): : 1861 - 1870
  • [44] Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
    Packard, Chris J.
    Pirillo, Angela
    Tsimikas, Sotirios
    Ference, Brian A.
    Catapano, Alberico L.
    CARDIOVASCULAR RESEARCH, 2024, 119 (18) : 2843 - 2857
  • [45] Immunochemical methods for quantification of human apolipoprotein C-III
    Kashyap, ML
    PLASMA LIPOPROTEINS, PT C, 1996, 263 : 208 - 218
  • [46] Apolipoprotein C-III, an important player in lipoprotein metabolism
    Fruchart, JC
    Clavey, V
    Luc, G
    Dallongeville, J
    Staels, B
    Auwerx, J
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 631 - 638
  • [47] Apolipoprotein C-III in patients with systemic lupus erythematosus
    Candelaria Martín-González
    Carmen Ferrer-Moure
    Juan Carlos Quevedo-Abeledo
    Antonia de Vera-González
    Alejandra González-Delgado
    Julio Sánchez-Martín
    Miguel Á. González-Gay
    Iván Ferraz-Amaro
    Arthritis Research & Therapy, 24
  • [48] Uncovering the role of apolipoprotein C-III in insulin resistance
    Aguilar-Recarte, David
    Palomer, Xavier
    Vazquez-Carrera, Manuel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (02): : 108 - 115
  • [49] Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen
    Valdivielso, Pedro
    Prieto, Inmaculada Coca
    MED, 2024, 5 (06): : 493 - 494
  • [50] Tryptophan Probes at the Apolipoprotein C-III and Membrane Interface
    Walker, Robert L.
    Pfefferkorn, Candace M.
    He, Yi
    Lee, Jennifer C.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 77A - 77A
12345